A study of the possible association between adenosine A2A receptor gene polymorphisms and attention-deficit hyperactivity disorder traits

Genes, Brain and Behavior

Volumn 12, Issue 3, 2013, Pages 305-310

  Molero, Y ^a   Gumpert, C ^a   Serlachius, E ^a   Lichtenstein, P ^a   Walum, H ^a   Johansson, D ^b   Anckarsater H ^c   Westberg, L ^b   Eriksson, E ^b   Halldner, L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Karolinska Institutet ^*  (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adenosine A2A receptor (ADORA2A); ADHD; Association study; Gene polymorphisms

Indexed keywords

ADENOSINE A2A RECEPTOR;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC TRAIT; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ADENOSINE A2A;

ANIMALIA;

EID: 84875807441     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12015     Document Type: Article

References (36)

1. Alsene, K., Deckert, J., Sand, P. & de Wit, H. (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropharmacology 28, 1694-1702.
2. Anckarsäter, H., Lundström, S., Kollberg, L., Kerekes, N., Palm, C., Carlström, E., Lângström, N., Magnusson, P., Halldner, L., Bölte, S., Gillberg, G., Gumpert, C., Râstam, M. & Lichtenstein, P. (2011) The Child and Adolescent Twin Study in Sweden (CATSS). Twin Res Hum Genet 14, 495-508.
3. Andreassi, M.G., Laghi Pasini, F., Picano, E., Capecchi, P.L., Pompella, G., Foffa, I., Borghini, A. & Sicari, R. (2011) Adenosine A2A receptor gene polymorphism (1976C>T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy. Pharmacogenet Genomics 21, 469-475.
4. Arnsten, A.F. (2006) Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry 67, 7-12.
5. Canals, M., Marcellino, D., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S.R., Neve, K., Fuxe, K., Agnati, L.F., Woods, A.S., Ferré, S., Lluis, C., Bouvier, M. & Francoa, R. (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278, 46741-46749.
6. Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. & de Wit, H. (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33, 2791-2800.
7. Chudasama, Y. & Robbins, T.W. (2006) Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 73, 19-38.
8. Cortese, S., Konofal, E., Yateman, N., Mouren, M.C. & Lecendreux, M. (2006) Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature. Sleep 29, 504-511.
9. Cunha, R.A. (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38, 107-125.
10. Cunha, R.A., Ferre, S., Vaugeois, J.M. & Chen, J.F. (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 14, 1512-1524.
11. Evans, D.M. & Martin, N.G. (2000) The validity of twin studies. GeneScreen 1, 77-79.
12. Faraone, S.V., Perlis, R.H., Doyle, A.E., Smoller, J.W., Goralnick, J.J., Holmgren, M.A. & Sklar, P. (2010) Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 33, 159-180.
13. Faraone, S.V., Perlis, R.H., Doyle, A.E., Smoller, J.W., Goralnick, J.J., Holmgren, M.A. et al. (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57, 1313-1323.
14. Faraone, S.V., Biederman, J., Spencer, T.J. & Aleardi, M. (2006) Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed 8, 4.
15. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Linden, J. & Muller, C.E. (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update. Pharmacol Rev 63, 1-4.
16. Freitag, C.M., Agelopoulos, K., Huy, E., Rothermundt, M., Krakowitzky, P., Meyer, J., Deckert, J., von Gontard, A. & Hohoff, C. (2010) Adenosine A2A receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder. Eur Child Adolesc Psychiatry 19, 67-74.
17. Hamilton, S.P., Slager, S.L., De Leon, A.B., Heiman, G.A., Klein, D.F., Hodge, S.E., Weissman, M.M., Fyer, A.J. & Knowles, J.A. (2004) Evidence for genetic linkage between a polymorphism in the adenosine A2A receptor and panic disorder. Neuropsychopharmacology 29, 558-565.
18. Hannelius, U., Gherman, L., Mäkelä, V., Lindstedt, A., Zucchelli, M., Lagerberg, C., Tybring, G. & Lindgren, C.M. (2007) Large-scale zygosity testing using single nucleotide polymorphisms. Twin Res Hum Genet 10, 604-625.
19. Hansson, S.L., Svanstrom Rojvall, A., Rastam, M., Gillberg, C. & Anckarsater, H. (2005) Psychiatric telephone interview with parents for screening of childhood autism - tics, attention-deficit hyperactivity disorder and other comorbidities (A-TAC): preliminary reliability and validity. Br J Psychiatry 187, 262-267.
20. Hohoff, C., McDonald, J.M., Baune, B.T., Cook, E.H., Deckert, J. & de Wit, H. (2005) Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet 139B, 42-44.
21. Jolin, E.M., Weller, R.A. & Weller, E.B. (2012) Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. J Affect Disord 136, 222-228.
22. Komar, A.A. (2007) Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 8, 1075-1080.
23. Larson, T., Anckarsater, H., Gillberg, C., Stahlberg, O., Carlstrom, E., Kadesjo, B. Râstam, M., Lichtenstein, P. & Gillberg, C. (2010) The autism--tics, AD/HD and other comorbidities inventory (A-TAC): further validation of a telephone interview for epidemiological research. BMC Psychiatry 10, 1-11.
24. Ledent, C., Vaugeois, J.M., Schiffmann, S.N., Pedrazzani, T., El Yacoubi, M., Vanderhaegen, J.J., Costentin, J., Heath, J. K., Vassart, G. & Parmentier, M. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674-678.
25. Lesch, K.P., Timmesfeld, N., Renner, T.J., Halperin, R., Röser, C., Nguyen, T.T., Craig, D.W., Romanos, J., Heine, M., Meyer, J., Freitag, C., Warnke, A., Romanos, M., Schäfer, H., Walitza, S., Reif, A., Stephan, D.A. & Jacob, C. (2008) Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115, 1573-1585.
26. Neale, B.M., Lasky-Su, J., Franke, B., et al. (2008) Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B, 1337-1344.
27. Neale, B.M., Medland, S.E., Ripke, S., et al. (2010) Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49, 884-897.
28. Ottoni, G.L., Lucchese, I.C., Martins, F., Grillo, R.W., Bogo, M.R. & Lara, D.R. (2005) Association between 2592C>TINS polymorphism of adenosine A2A receptor gene and schizophrenia. Schizophr Bull 31, 274.
29. Pires, V.A., Pamplona, F.A., Pandolfo, P., Fernandes, D., Prediger, R.D. & Takahashi, R.N. (2009) Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder. Behav Pharmacol 20, 134-145.
30. Pires, V.A., Pamplona, F.A., Pandolfo, P., Prediger, R.D. & Takahashi, R.N. (2010) Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD). Behav Brain Res 215, 39-44.
31. Porkka-Heiskanen, T. (1999) Adenosine in sleep and wakefulness. Ann Med 31, 125-129.
32. Rogers, P.J., Hohoff, C., Heatherley, S.V., Mullings, E.L., Maxfield, P.J., Evershed, R.P., Deckert, J. & Nutt, D.J. (2010) Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 35, 1973-1983.
33. Svenningsson, P., Le Moine, B., Kull, B., Sunahara, R., Bloch, B. & Fredholm, B.B. (1997) Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80, 1171-1185.
34. Svenningsson, P., Le Moine, C., Fisone, G. & Fredholm, B.B. (1999) Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59, 355-396.
35. Takahashi, R.N., Pamplona, F.A. & Prediger, R.D. (2008) Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front Biosci 13, 2614-2632.
36. Zhou, K., Dempfle, A., Arcos-Burgos, M., Bakker, S.C., Banaschewski, T. & Biederman, J. (2008) Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B, 1392-1398.